What happened with this . .premature ejaculation This is news to me!
SAN DIEGO, 2011-02-14 16:14 CET (GLOBE NEWSWIRE) --Apricus Biosciences, Inc.
('Apricus Bio') (Nasdaq:APRI), announced today that
it has entered into a licensing agreement granting Neopharm Group ('Neopharm')
the exclusive rights to market and sell Vitaros(r), Apricus Bio's treatment for
erectile dysfunction ('ED') and, when and if available, its formulation for the
treatment of premature ejaculation ('PE'), in Israel and the Palestinian
Territories of the Gaza Strip and the West Bank.
Market Data 
Markets 
AI
